Lv2
144 积分 2025-11-08 加入
Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03
1个月前
已完结
Sequencing antibody–drug conjugates in metastatic breast cancer: A systematic review
1个月前
已完结
Regulation of tumorigenesis and ferroptosis in non-small cell lung cancer by a novel BBOX1-AS1/miR-326/PROM2 axis
9个月前
已完结
Anti-tumoral activity of the human-specific duplicated form of α7-nicotinic receptor subunit in tobacco-induced lung cancer progression
9个月前
已完结
RETRACTED: Limbal stem cell deficiency secondary to systemic daptopotamab deruxtecan (Dato-DXd): A case report and literature review
9个月前
已完结
Transition of average drug‐to‐antibody ratio of trastuzumab deruxtecan in systemic circulation in monkeys using a hybrid affinity capture liquid chromatography‐tandem mass spectrometry
9个月前
已完结
Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody–Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer
9个月前
已完结
Trastuzumab Deruxtecan for HER2+ Advanced Breast Cancer
9个月前
已完结
Visualization of Intratumor Pharmacokinetics of [fam-] Trastuzumab Deruxtecan (DS-8201a) in HER2 Heterogeneous Model Using Phosphor-integrated Dots Imaging Analysis
9个月前
已完结
Pharmacological and clinical study results of trastuzumab deruxtecan (T-DXd, ENHERTU<sup>®</sup>)
9个月前
已完结
皖公网安备34019202002308
